Journal Article

Efavirenz and <i>CYP2B6</i> Polymorphism: Implications for Drug Toxicity and Resistance

David Nolan, Elizabeth Phillips and Simon Mallal

in Clinical Infectious Diseases

Published on behalf of Infectious Diseases Society of America

Volume 42, issue 3, pages 408-410
Published in print February 2006 | ISSN: 1058-4838
Published online February 2006 | e-ISSN: 1537-6591 | DOI: https://dx.doi.org/10.1086/499369
Efavirenz and CYP2B6 Polymorphism: Implications for Drug Toxicity and Resistance

More Like This

Show all results sharing these subjects:

  • Infectious Diseases
  • Immunology
  • Public Health and Epidemiology
  • Microbiology

GO

Show Summary Details

Journal Article.  2060 words. 

Subjects: Infectious Diseases ; Immunology ; Public Health and Epidemiology ; Microbiology

Full text: subscription required

How to subscribe Recommend to my Librarian

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.